Quantcast
Last updated on April 17, 2014 at 10:27 EDT

Latest Medegen Inc. Stories

2010-04-05 07:00:00

SAN DIEGO, April 5 /PRNewswire-FirstCall/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical device company, today announced an agreement to acquire Medegen, a leading innovator in clinically differentiated needleless access valves and administration sets that deliver intravenous (IV) medication to patients, for $225 million in cash. "Medegen is an ideal strategic fit with CareFusion due to the complementary nature of our infusion product lines, R&D investments, and our focus...

2008-08-18 09:01:01

Maximus, a business unit of leading infusion therapy firm Medegen Inc., today announced that as a result of a Co-Marketing Agreement between C.R. Bard and Medegen Inc., the MaxPlus(R) Clear(TM) needleless access connector will now be included in peripherally inserted central catheter (PICC) kits sold by Bard Access Systems. The agreement provides the extra benefits of the MaxPlus Clear product to users of Bard PowerPICC SOLO*, the newly launched PICC designed to provide the efficiency of...

2008-06-16 09:01:18

Maximus, a business unit of leading infusion therapy firm Medegen Inc., will exhibit at the Association for Professionals in Infection Control and Epidemiology (APIC) annual scientific conference, June 15-17 in Denver, Colorado. The exhibit will feature the new MaxPlus(R) Clear, the first and only clear positive displacement connector for use in patient care, as well as two award-winning clinical research posters. The first, an abstract authored by Victor Lange, ICP, CRC entitled...